JP2015503106A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015503106A5 JP2015503106A5 JP2014546631A JP2014546631A JP2015503106A5 JP 2015503106 A5 JP2015503106 A5 JP 2015503106A5 JP 2014546631 A JP2014546631 A JP 2014546631A JP 2014546631 A JP2014546631 A JP 2014546631A JP 2015503106 A5 JP2015503106 A5 JP 2015503106A5
- Authority
- JP
- Japan
- Prior art keywords
- rheumatoid arthritis
- tenascin
- level
- patient
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1121280.0 | 2011-12-12 | ||
| GB201121280A GB201121280D0 (en) | 2011-12-12 | 2011-12-12 | Biomarker |
| GB1214806.0 | 2012-08-20 | ||
| GBGB1214806.0A GB201214806D0 (en) | 2012-08-20 | 2012-08-20 | Biomarker |
| PCT/GB2012/053104 WO2013088140A2 (en) | 2011-12-12 | 2012-12-12 | Biomarker and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015503106A JP2015503106A (ja) | 2015-01-29 |
| JP2015503106A5 true JP2015503106A5 (enExample) | 2015-12-10 |
| JP6158825B2 JP6158825B2 (ja) | 2017-07-05 |
Family
ID=47561655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014546631A Expired - Fee Related JP6158825B2 (ja) | 2011-12-12 | 2012-12-12 | テネイシンｃおよび関節リウマチにおけるその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20140322211A1 (enExample) |
| EP (1) | EP2791686B1 (enExample) |
| JP (1) | JP6158825B2 (enExample) |
| KR (1) | KR20140109956A (enExample) |
| CN (1) | CN104105967B (enExample) |
| BR (1) | BR112014014295A2 (enExample) |
| CA (1) | CA2894746A1 (enExample) |
| IN (1) | IN2014MN01372A (enExample) |
| WO (1) | WO2013088140A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201400521D0 (en) * | 2014-01-13 | 2014-02-26 | Isis Innovation | Biomarker and uses thereof |
| GB201602413D0 (en) | 2016-02-10 | 2016-03-23 | Nascient Ltd | Method |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6232071B1 (en) * | 1990-06-11 | 2001-05-15 | Gilead Sciences, Inc. | Tenascin-C nucleic acid ligands |
| JP4488746B2 (ja) * | 2002-02-26 | 2010-06-23 | シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ | 抗−ヒトテネイシンモノクローナル抗体 |
| US20060115862A1 (en) * | 2004-11-17 | 2006-06-01 | Duke University | Anti-tenascin monoclonal antibody immunoassays and diagnostic kits |
| KR100958840B1 (ko) * | 2007-08-28 | 2010-05-24 | 단국대학교 산학협력단 | 항－테나신 c 펩타이드 및 그의 용도 |
| JP2011501147A (ja) * | 2007-10-22 | 2011-01-06 | ノバルティス・フォルシュングスシュティフトゥング・ツヴァイクニーダーラッスング・フリードリッヒ・ミーシェー・インスティトゥート・フォー・バイオメディカル・リサーチ | 結腸癌のバイオマーカーとしてのテネイシン−ｗの使用 |
| FR2930036B1 (fr) * | 2008-04-11 | 2010-05-07 | Assist Publ Hopitaux De Paris | Procede de diagnostic d'une hypertension arterielle pulmonaire. |
| GB0904355D0 (en) * | 2009-03-13 | 2009-04-29 | Imp Innovations Ltd | Biological materials and uses thereof |
| CN102884434B (zh) * | 2010-05-12 | 2015-08-19 | 希尔氏宠物营养品公司 | 用于诊断、控制和预防犬科动物炎症及减轻犬科动物炎性病况的方法 |
| JP5360922B2 (ja) * | 2011-08-03 | 2013-12-04 | 国立大学法人山口大学 | 新規虚血マーカー及びこれを用いた虚血状態の検出方法 |
-
2012
- 2012-12-12 KR KR1020147019387A patent/KR20140109956A/ko not_active Withdrawn
- 2012-12-12 JP JP2014546631A patent/JP6158825B2/ja not_active Expired - Fee Related
- 2012-12-12 US US14/364,487 patent/US20140322211A1/en not_active Abandoned
- 2012-12-12 CA CA2894746A patent/CA2894746A1/en not_active Abandoned
- 2012-12-12 BR BR112014014295A patent/BR112014014295A2/pt not_active IP Right Cessation
- 2012-12-12 WO PCT/GB2012/053104 patent/WO2013088140A2/en not_active Ceased
- 2012-12-12 EP EP12816091.8A patent/EP2791686B1/en not_active Not-in-force
- 2012-12-12 CN CN201280068536.6A patent/CN104105967B/zh not_active Expired - Fee Related
-
2014
- 2014-07-05 IN IN1372MUN2014 patent/IN2014MN01372A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Martinez et al. | Idiopathic pulmonary fibrosis | |
| Nadeem et al. | Serum inflammatory markers in obstructive sleep apnea: a meta-analysis | |
| van de Logt et al. | S 100 A 12: A noninvasive marker of inflammation in inflammatory bowel disease | |
| JP2012523009A5 (enExample) | ||
| Berezin et al. | Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation | |
| HK1258292A1 (zh) | 使用il23途徑生物標誌物預測il23拮抗劑的臨床應答 | |
| JP2010516678A5 (enExample) | ||
| Menegat et al. | Cytokine expression in gingival and intestinal tissues of patients with periodontitis and inflammatory bowel disease: An exploratory study | |
| JP2014519018A5 (enExample) | ||
| JP2019528455A (ja) | 新規な肝硬変または肝線維症のマーカー | |
| JP2011501176A5 (enExample) | ||
| JP2015508887A5 (enExample) | ||
| JP2015530868A5 (enExample) | ||
| CN102770766A (zh) | 脑脊液中的β淀粉样聚集体作为阿尔茨海默病的生物标记 | |
| JP2018004657A5 (enExample) | ||
| CN107345970A (zh) | 一种可用于首发精神分裂症诊断的外周血生物标志物 | |
| JP2018504909A5 (enExample) | ||
| JP2017508144A5 (enExample) | ||
| Singh et al. | Idiopathic pulmonary fibrosis: where do we stand and how far to go | |
| JP2010509576A5 (enExample) | ||
| Berastegui et al. | Biomarkers of pulmonary rejection | |
| WO2009133197A3 (en) | Levels of april in serum and use in diagnostic methods | |
| JP2015503106A5 (enExample) | ||
| Ciprandi et al. | Forced expiratory flow between 25% and 75% of vital capacity may be a marker of bronchial impairment in allergic rhinitis | |
| JP2016502406A5 (enExample) |